Cardiotoxicity Evaluation of Tyrosine Kinase Inhibition using Human Induced Pluripotent Stem Cell-derived Healthy and Long QT Syndrome Cardiomyocytes. acbr. 2024;8(2):54-72. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/15054